Contrast

Contact

Share

MyChart

Help

Yale New Haven Health names Vincent Tammaro executive vice president and chief financial officer

Monday, April 25, 2016

NEW HAVEN, CT — Vincent Tammaro has been appointed as executive vice president and chief financial officer for Yale New Haven Health System and chief financial officer for Yale New Haven Hospital (YNHH).

“As an outstanding leader in his field and a member of Yale New Haven Health since 2002, we are very excited Vincent will bring his wealth of experience to his new position,” said Marna P. Borgstrom, president and CEO, Yale New Haven Health System and CEO of YNHH. “Vincent is an accomplished executive who understands our system, culture and the unique aspects of Connecticut-based health care financing and delivery.”

Tammaro began at YNHHS in 2002 as director of financial reporting and earned the promotion to senior vice president of corporate finance in 2012. During his YNHHS tenure, Tammaro has integrated financial leadership with operations and played a key role in initiatives such as the Saint Raphael acquisition and integration. In 2014, he completed a GE Health Management Academy fellows program.

A graduate of Pace University’s School of Business, Tammaro began his career at Sound Shore Medical Center in New Rochelle before joining Ernst and Young as a practicing certified public accountant. 


Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org

Similar Articles

9/15/2021

Marna Borgstrom to retire in 2022 as CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – After more than 43 years of exceptional service, Marna P. Borgstom has announced her intent to retire as chief executive officer of Yale New Haven Health. Her retirement is effective on March 25 2022.

9/15/2021

Christopher O’Connor to become CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – Christopher O’Connor has been named the CEO of Yale New Haven Health (YNHHS), effective March 25, 2022 when current CEO Marna P. Borgstrom retires, announced Vince Calarco, Chair of the YNHHS Board of Trustees. O’Connor currently serves as president of the Health System having been named to that position in August of 2020.

9/1/2021

Outpatient Monoclonal Antibody Treatment decreases hospitalization risk in COVID-19 patients

New Haven, CT (September 1, 2021) – While not a new treatment, monoclonal antibody therapy is being administered more regularly and effectively to patients with mild to moderate COVID-19 with excellent results.